Epidemiology of Infectious Diseases – Microbiology: A Systems Approach (Chapter 14 Study Notes)

Chapter 14: Epidemiology of Infectious Diseases

14.1 Epidemiology Basics and History

Epidemiology is a foundational discipline in microbiology, focusing on the study of disease mechanisms, causes, and distribution within populations. It informs public health strategies and disease prevention efforts.

• Definition: Epidemiology is the study of the mechanism of getting disease based on the causes of disease and other factors.

• Purpose: The main goal is to identify and prevent factors that contribute to disease occurrence.

• Key Questions: Epidemiologists ask: What, Where, When, Why, and How regarding disease events.

• Example: An increase in cancer rates in a specific region or unexplained respiratory symptoms in hospital admissions.

Public Health is closely linked to epidemiology, involving practices and activities designed to prevent diseases and promote wellness at community, national, or global levels.

• Public health initiatives are informed by epidemiological studies.

• Examples include pandemic control, suicide prevention, maternal mortality reduction, Chlamydia prevention, and opioid use detection.

14.2 Units of Measure in Epidemiology

Quantitative measures are essential for tracking disease frequency, outcomes, and transmission. These metrics help compare disease impact across populations and time periods.

• Incidence: Number of new cases of a disease in a population over a specific time period.

• Prevalence: Total number of existing cases (new and old) in a population at a given time.

• Morbidity: Frequency of disease occurrence.

• Mortality: Frequency of deaths due to a disease.

Formulas:

• Incidence Rate: $\text{Incidence Rate} = \frac{\text{Number of new cases}}{\text{Population at risk} \times \text{Time period}}$

• Prevalence Rate: $\text{Prevalence Rate} = \frac{\text{Total number of cases}}{\text{Total population}}$

14.3 Infectious Disease Epidemiology

This subfield focuses on the spread, control, and prevention of infectious diseases. It uses mathematical tools and study designs to understand disease dynamics.

• Epidemic Curve Patterns:

  • Point-source epidemic: All victims exposed to a single source at the same time.

  • Common-source epidemic: Exposure to a single source over a period of time.

  • Propagated epidemic: Person-to-person transmission, spreading over time (e.g., influenza).

• Key Terms:

  • Index case: The first patient identified in an epidemiological investigation.

  • Outbreak: Sudden increase in cases in a specific area.

  • Epidemic: Outbreak over a greater area and time period than expected.

  • Pandemic: Epidemic occurring over multiple continents.

  • Sporadic disease: Occurs occasionally and irregularly.

  • Endemic disease: Seen at a steady frequency in a particular location.

Mathematical Tools and Study Designs

Various study designs and statistical criteria are used to establish causation and understand disease patterns.

• Types of Studies:

  • Cross-sectional studies: Data on exposure and disease collected at a single point in time.

  • Case-control studies: Compare exposure history between those with and without the disease.

  • Cohort studies: Follow a group over time to monitor disease development and exposures.

  • Randomized Control Trials (RCTs): Test interventions in experimental and control groups.

• Bradford Hill Criteria: Used to assess causation between exposure and outcome.

  • Strength of association

  • Consistency

  • Specificity

  • Temporality

  • Biological plausibility

Screening and Diagnostic Tests

Screening tests are used to detect diseases early, often before symptoms appear. Diagnostic tests confirm disease presence, usually with higher accuracy but more invasiveness.

• Sensitivity: Ability of a test to correctly identify those with the disease (true positives).

• Specificity: Ability of a test to correctly identify those without the disease (true negatives).

• False positives/negatives: Important to consider in test interpretation.

• Example: Pap smear (screening) vs. biopsy (diagnostic) for cervical cancer.

Surveillance and Notifiable Diseases

Surveillance involves systematic data collection, analysis, and reporting of disease occurrence, mortality, morbidity, and transmission.

• Notifiable diseases: Legally required to be reported to authorities due to their public health significance.

• CDC: Central agency for tracking infectious diseases in the U.S.

• Morbidity and Mortality Report: Weekly publication by the CDC.

Healthcare-Associated Infections (HAIs)

HAIs are infections acquired during hospital or healthcare facility stays. They are a major concern for patient safety and public health.

• Common HAIs:

  • Catheter-associated urinary tract infections (CAUTI)

  • Central line-associated bloodstream infections (CLABSI)

  • Surgical site infections (SSI)

  • Ventilator-associated events (VAE)

• Control Measures:

  • Universal precautions (medical and surgical asepsis)

  • Infection-control officers

  • Handwashing, disinfection, patient isolation

Reproducibility Rate and Case Fatality Rate

These metrics help assess the potential impact and severity of infectious diseases.

• Basic reproduction rate (R0): Average number of secondary cases produced by one infected individual in a susceptible population.

• Case fatality rate (CFR): Proportion of infected individuals who die from the disease.

Formulas:

• Basic reproduction rate: $R_0 = \frac{\text{Number of secondary cases}}{\text{Number of primary cases}}$

• Case fatality rate: $\text{CFR} = \frac{\text{Number of deaths}}{\text{Number of infected individuals}} \times 100\%$

Herd Immunity and Vaccines

Vaccines are critical for controlling infectious diseases and achieving herd immunity, which protects even those who are not immune.

• Herd immunity: Occurs when a significant portion of a population is immune, limiting disease spread.

• Achieved by: Surviving infection or vaccination.

• Vaccine approval: Involves multiple trial phases and post-distribution monitoring (Phase IV).

• Adverse event reporting: VAERS system allows anyone to report vaccine side effects.

• Compensation: VCIP program provides compensation for vaccine injuries, even without proven causation.

Emerging and Re-emerging Diseases

Newly identified or previously controlled diseases can become significant threats due to factors like travel, habitat changes, and drug resistance.

• Emerging diseases: Caused by newly identified microbes (e.g., SARS, novel influenza strains).

• Re-emerging diseases: Previously controlled but now increasing in prevalence.

• Global Disease Detection (GDD): International collaboration to monitor and limit epidemics.

Neglected Parasitic Infections (NPIs)

NPIs are parasitic diseases often found in impoverished communities and among immigrants from endemic regions.

• Examples:

  • Chagas disease – Trypanosoma cruzi

  • Neurocysticercosis – Taenia solium

  • Toxocariasis – tissue-traveling worms

  • Toxoplasmosis – protozoan infection

  • Trichomoniasis – genital tract protozoal infection

Bioterrorism and Agroterrorism

Intentional use of microorganisms or biological toxins to cause harm to humans, animals, or plants. Surveillance and policy development are essential to prevent such events.

• Example: 2001 anthrax attacks in the U.S.

• Agroterrorism: Targeting agriculture and food supply.

Summary Table: Key Epidemiological Terms

Term	Definition	Example
Incidence	Number of new cases in a time period	New COVID-19 cases in a month
Prevalence	Total cases at a given time	Total HIV cases in a population
Endemic	Steady frequency in a location	Malaria in certain regions
Epidemic	Outbreak over expected levels	Influenza outbreak in a city
Pandemic	Outbreak over multiple continents	COVID-19 pandemic
R0	Basic reproduction rate	COVID-19 R0 ≈ 2–5
CFR	Case fatality rate	Ebola CFR ≈ 50%

Additional info:

• Some content inferred from context and standard epidemiology curriculum.

• Definitions and formulas expanded for clarity and completeness.